3-amino-1-phenylbutane has been researched along with labetalol in 3 studies
*Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. [MeSH]
*Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, FS; Axelson, JE; Hall, C; Kwan, E; Rurak, DW; Yeleswaram, K | 1 |
| Changchit, A; Gal, J; Zirrolli, JA | 1 |
| Gal, J; Lichtenstein, PS; Zirrolli, JA | 1 |
3 other study(ies) available for 3-amino-1-phenylbutane and labetalol
| Article | Year |
|---|---|
Identification and quantitation of an oxidative metabolite of labetalol in sheep: pharmacokinetic and metabolic implications.
Topics: Animals; Bile; Butylamines; Female; Gas Chromatography-Mass Spectrometry; Labetalol; Sheep | 1992 |
Stereospecific gas chromatographic/mass spectrometric assay of the chiral labetalol metabolite 3-amino-1-phenylbutane.
Topics: Adult; Butylamines; Gas Chromatography-Mass Spectrometry; Humans; Labetalol; Male | 1991 |
Labetalol is metabolized oxidatively in humans.
Topics: Adult; Biotransformation; Butylamines; Chromatography, Thin Layer; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Oxidation-Reduction | 1988 |